| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0140-6736(92)93078-2 |
| P698 | PubMed publication ID | 1357453 |
| P2093 | author name string | M. J. Langman | |
| R. P. Walt | |||
| S. G. Mann | |||
| J. Cottrell | |||
| N. P. Freemantle | |||
| P433 | issue | 8827 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | famotidine | Q411159 |
| P304 | page(s) | 1058-1062 | |
| P577 | publication date | 1992-10-01 | |
| 1992-10-31 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Continuous intravenous famotidine for haemorrhage from peptic ulcer | |
| P478 | volume | 340 |
| Q40985813 | A cost-effective approach to the patient with peptic ulcer bleeding |
| Q41388280 | A practical guide to the management of bleeding ulcers |
| Q35572520 | Acid suppression in critically ill patients: what does the evidence support? |
| Q36209033 | Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer |
| Q38522353 | Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots |
| Q40490684 | Current management of bleeding peptic ulcer. A review |
| Q72693693 | Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? |
| Q28346263 | Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points |
| Q51590801 | Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects. |
| Q33617657 | Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study |
| Q72313326 | Gastrointestinal bleeding in children |
| Q35621855 | Gastrointestinal hemorrhage: is the surgeon obsolete? |
| Q40392368 | Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use. |
| Q33772529 | How evidence-based are current guidelines for managing patients with peptic ulcer bleeding? |
| Q36180419 | Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers |
| Q71860092 | Maintenance of gastric pH above 6 with intravenous famotidine in patients with a bleeding duodenal ulcer |
| Q82465081 | Non-variceal upper gastrointestinal bleeding |
| Q75209400 | Nonvariceal upper gastrointestinal bleeding |
| Q34427247 | Optimizing the intragastric pH as a supportive therapy in upper GI bleeding |
| Q80359707 | Oral proton pump inhibitors are as effective as endoscopic treatment for bleeding peptic ulcer: a prospective, randomized, controlled trial |
| Q31987987 | Peptic ulcer bleeding: comparison of two hemostatic procedures |
| Q36478873 | Review article: acid-related disease--what are the unmet clinical needs? |
| Q35558225 | The role of acid suppression in the management and prevention of gastrointestinal hemorrhage associated with gastroduodenal ulcers |
| Q54334348 | [Guidelines for the diagnosis and treatment of acute non-variceal upper gastrointestinal bleeding]. |
Search more.